Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Universal Ibogaine Inc
V.IBO
Alternate Symbol(s):
IBOGF
Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine...
detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:IBO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Next
(2)
•••
ashokswain861
X
View Profile
View Bullboard History
Post by
ashokswain861
on Jun 24, 2022 9:44am
Universal Ibogaine Inc. Market Graph
Universal Ibogaine Inc. holds a significant position over the TSX-V market with its greater difference between the lower and higher ranges of trading, which is $0.0400-$0.2500 in the last 52 weeks
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 23, 2022 2:27pm
$IBO shares fired up on the TSX-V
$IBO has been running tenaciously while a firm market hitting resolution, the shares are currently being traded on the TSX-V at $0.045 with a perceptible rise
(2)
•••
zames007
X
View Profile
View Bullboard History
Post by
zames007
on Jun 23, 2022 11:50am
$IBOGF agreement with blue digital media utter additional
Blue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common
...more
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Comment by
TRADERCONNECTS
on Jun 23, 2022 11:36am
RE:$IBO @BNNBloomberg Feature Article 💥
$IBO has the market capitalization value of $8.5M+ with enterprise value of $7.51M
(17)
•••
MatthewDavies
X
View Profile
View Bullboard History
Post by
MatthewDavies
on Jun 23, 2022 11:35am
$IBO Leading the Journey to Addiction Free Living
We are creating a new standard for addiction treatment using patient centred, evidence based protocols and nouveau modalities. https://universalibogaine.com/wp-content/uploads/2022/02/UI_FactSheet
...more
(8)
•••
DanielOTC
X
View Profile
View Bullboard History
Post by
DanielOTC
on Jun 23, 2022 11:22am
$IBO @BNNBloomberg Feature Article 💥
$IBO is developing a #natural alternative #medicine intended to take on today's drug addiction crisis head-on! Learn all about the development of our multi-modal and prolonged
...more
(2)
•••
zames007
X
View Profile
View Bullboard History
Post by
zames007
on Jun 23, 2022 11:11am
Addiction treatment by $IBOGF
Universal Ibogaine Inc. is a life science company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model through a planned Canadian
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 23, 2022 10:49am
$IBOGF announced a crucial addition of clinical trials direc
Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 23, 2022 10:45am
$PQE Market Insights
Potential Healthcare Stocks That Are Making Investors Insane About The Profit https://mailchi.mp/2a1c416eb7df/potential-healthcare-stocks-that-are-making-investors-insane-about-the-profit
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Comment by
TRADERCONNECTS
on Jun 23, 2022 9:52am
RE:Universal Ibogaine operates as a life science company
$IBOGF with a steal deal on OTC,
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 23, 2022 7:41am
Universal Ibogaine operates as a life science company
A Canadian life science company, Universal Ibogaine, is publicly traded over the OTC with $IBOGF as the ticker symbol, which is actively engaged in treating opioid addiction.
(2)
•••
zames007
X
View Profile
View Bullboard History
Post by
zames007
on Jun 23, 2022 6:34am
$IBOGF soon to commission contemporary addiction treatment
At the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat
...more
(6)
•••
Tradeconnects
X
View Profile
View Bullboard History
Comment by
Tradeconnects
on Jun 22, 2022 2:28pm
RE:Universal Ibogaine teams up with IR firm Blue Digital
yes After this announcement $IBOGF stole the show with a marvelous run on the OTC
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Comment by
TRADERCONNECTS
on Jun 22, 2022 2:06pm
RE:$IBO announced a vital addition of clinical trials director
$IBO having endless potential
(8)
•••
DanielOTC
X
View Profile
View Bullboard History
Post by
DanielOTC
on Jun 22, 2022 11:44am
$IBO announced a vital addition of clinical trials director
Julie Dumouchel has been named Director of Clinical Trials at Universal Ibogaine Inc., which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer